(US10306883) Use of porous polymer materials for storage of biological samples 机翻标题: 暂无翻译,请尝试点击翻译按钮。

源语言标题
(US10306883) Use of porous polymer materials for storage of biological samples
公开号/公开日
US10306883US20140127669 / 2019-06-042014-05-08
申请号/申请日
US14/151,689 / 2014-01-09
发明人
HILDER EMILY FRANCESHON WEI BOON;
申请人
UNIVERSITY OF TASMANIA;
主分类号
IPC分类号
A01N-001/02 B01J-020/26 B01J-020/28 B01J-020/32 B01L-003/00 C12M-001/00
摘要
(US10306883) The present invention generally relates to the use of porous polymer materials as a medium for the storage of biological samples. The present invention also relates to a method of drying and storage of biological samples on the porous polymer materials. The biological samples include blood and blood plasma samples.
机翻摘要
暂无翻译结果,您可以尝试点击头部的翻译按钮。
地址
代理人
(US10306883) Wilson Sonsini Goodrich & Rosati
代理机构
;
优先权号
2011AU-0902782 2012WO-AU00826
主权利要求
(US10306883) What is claimed is: 1. A method of storing a whole blood sample for future analysis comprising applying the whole blood sample directly to a porous polymer monolith material medium and drying the whole blood sample such that the whole blood sample at least partially solidifies and adsorbs or adheres to the porous polymer monolith material;   wherein the porous polymer monolith material medium is formed by a step-growth polymerization process, wherein the medium additionally comprises one or more supporting layers comprising a porous polymer matrix material, wherein the porous polymer matrix material of each of the one or more support layers is selected from a polyether, polyester, polycarbonate, polyanhydride, polythiophene polymer, and an epoxy resin, wherein the medium allows storage of the whole blood sample for at least one day, wherein the whole blood sample is applied directly to the medium, with the proviso that the porous polymer monolith material is polymerized onto or sits on the one or more supporting layers comprising the porous polymer matrix material without one or more intervening layers of functionality formed by photoinitiated grafting. 2. A method of storing a whole blood sample for future analysis comprising:   applying one or more whole blood samples directly to one or more regions of a porous polymer monolith material medium;   partially drying the one or more whole blood samples applied to the medium such that the whole blood sample adsorbs or adheres to the porous polymer monolith material;   optionally separating any one or more regions of the medium having the one or more whole blood sample applied thereto from regions without the one or more whole blood sample applied thereto; and   optionally further drying the one or more whole blood samples applied to the one or more regions of the medium;   wherein the porous polymer monolith material medium is formed by a step-growth polymerization process, wherein the medium additionally comprises one or more supporting layers comprising a porous polymer matrix material, wherein the porous polymer matrix material of each of the one or more support layers is selected from a polyether, polyester, polycarbonate, polyanhydride, polythiophene polymer, and an epoxy resin, wherein the medium allows storage of the whole blood sample for at least one day, wherein the whole blood sample is applied directly to the medium, with the proviso that the porous polymer monolith material is polymerized onto or sits on the one or more supporting layers comprising the porous polymer matrix material without one or more intervening layers of functionality formed by photoinitiated grafting. 3. A method of analysis of a whole blood sample comprising detecting and identifying an analyte from the whole blood sample, wherein the whole blood sample was directly applied to a porous polymer monolith material medium such that the whole blood sample adsorbs or adheres to the porous polymer monolith material and stored for at least one day prior to detecting and identifying the analyte;   wherein the porous polymer monolith material medium is formed by a step-growth polymerization process, wherein the medium additionally comprises one or more supporting layers comprising a porous polymer matrix material, wherein the porous polymer matrix material of each of the one or more support layers is selected from a polyether, polyester, polycarbonate, polyanhydride, polythiophene polymer, and an epoxy resin, wherein the medium allows storage of the whole blood sample for at least one day, wherein the whole blood sample is applied directly to the medium, with the proviso that the porous polymer monolith material is polymerized onto or sits on the one or more supporting layers comprising the porous polymer matrix material without one or more intervening layers of functionality formed by photoinitiated grafting. 4. A method for storing and subsequent analysis of a whole blood sample comprising one or more analytes selected from pharmaceutical agents, peptides, proteins, oligonucleotides, DNA, RNA, oligosaccharides and lipids, the method comprising:   applying the whole blood sample comprising the one or more analytes directly to a porous polymer monolith material medium, wherein the porous polymer monolith material medium is formed by a step-growth polymerization process, wherein the medium additionally comprises one or more supporting layers comprising a porous polymer matrix material, wherein the porous polymer matrix material of each of the one or more support layers is selected from a polyether, polyester, polycarbonate, polyanhydride, polythiophene polymer, and an epoxy resin, wherein the medium allows storage of the whole blood sample for at least one day, wherein the whole blood sample is applied directly to the medium, with the proviso that the porous polymer monolith material is polymerized onto or sits on the one or more supporting layers comprising the porous polymer matrix material without one or more intervening layers of functionality formed by photoinitiated grafting;   drying the whole blood sample applied to the medium such that the whole blood sample adsorbs or adheres to the porous polymer monolith material;   storing the whole blood sample in the medium for at least one day;   retrieving and optionally pre-treating the stored whole blood sample;   and   analyzing the retrieved and optionally pre-treated whole blood sample for the presence of one or more analytes. 5. The method of claim 1 wherein the porous polymer monolith material medium has an integral body with a pore size and a specific surface area adapted to facilitate the drying and storage of the biological fluid sample, wherein the pore size of the porous polymer monolith material is in the range of 5 to 10,000 nm and the specific surface area of the porous polymer monolith material when measured by nitrogen adsorption using BET isotherm is in the range of 0.5 to 1000 m2/g. 6. The method of claim 2 wherein the porous polymer monolith material medium has an integral body with a pore size and a specific surface area adapted to facilitate the drying and storage of the biological fluid sample, wherein the pore size of the porous polymer monolith material is in the range of 5 to 10,000 nm and the specific surface area of the porous polymer monolith material when measured by nitrogen adsorption using BET isotherm is in the range of 0.5 to 1000 m2/g. 7. The method of claim 3 wherein the porous polymer monolith material medium has an integral body with a pore size and a specific surface area adapted to facilitate the drying and storage of the biological fluid sample, wherein the pore size of the porous polymer monolith material is in the range of 5 to 10,000 nm and the specific surface area of the porous polymer monolith material when measured by nitrogen adsorption using BET isotherm is in the range of 0.5 to 1000 m2/g. 8. The method of claim 4 wherein the porous polymer monolith material medium has an integral body with a pore size and a specific surface area adapted to facilitate the drying and storage of the biological fluid sample, wherein the pore size of the porous polymer monolith material is in the range of 5 to 10,000 nm and the specific surface area of the porous polymer monolith material when measured by nitrogen adsorption using BET isotherm is in the range of 0.5 to 1000 m2/g. 9. The method of claim 1 wherein the porous polymer monolith material is incorporated with chemical functionality selected from the group consisting of hydrophilic groups and groups with ion exchange properties to facilitate pre-analysis of analytes in the whole blood sample or in situ elimination of undesirable components in the whole blood sample on the medium. 10. The method of claim 2 wherein the porous polymer monolith material is incorporated with chemical functionality selected from the group consisting of hydrophilic groups and groups with ion exchange properties to facilitate pre-analysis of analytes in the whole blood sample or in situ elimination of undesirable components in the whole blood sample on the medium. 11. The method of claim 3 wherein the porous polymer monolith material is incorporated with chemical functionality selected from the group consisting of hydrophilic groups and groups with ion exchange properties to facilitate pre-analysis of analytes in the whole blood sample or in situ elimination of undesirable components in the whole blood sample on the medium. 12. The method of claim 4 wherein the porous polymer monolith material is incorporated with chemical functionality selected from the group consisting of hydrophilic groups and groups with ion exchange properties to facilitate pre-analysis of analytes in the whole blood sample or in situ elimination of undesirable components in the whole blood sample on the medium. 13. The method of claim 1 wherein the step-growth polymerization process for the porous polymer monolith material comprises the polymerization of one or more monomers having one or more functional groups selected from: hydroxyl, carboxylic acid, anhydride, acyl halide, alkyl halide, acid anhydride, acrylate, methacrylate, aldehyde, amide, amine, guanidine, malimide, thiol, sulfonate, sulfonic acid, sulfonyl ester, carbodiimide, ester, cyano, epoxide, proline, disulfide, imidazole, imide, imine, isocyanate, isothiocyanate, nitro, azide, and combinations thereof. 14. The method of claim 2 wherein the step-growth polymerization process for the porous polymer monolith material comprises the polymerization of one or more monomers having one or more functional groups selected from: hydroxyl, carboxylic acid, anhydride, acyl halide, alkyl halide, acid anhydride, acrylate, methacrylate, aldehyde, amide, amine, guanidine, malimide, thiol, sulfonate, sulfonic acid, sulfonyl ester, carbodiimide, ester, cyano, epoxide, proline, disulfide, imidazole, imide, imine, isocyanate, isothiocyanate, nitro, azide, and combinations thereof. 15. The method of claim 3 wherein the step-growth polymerization process for the porous polymer monolith material comprises the polymerization of one or more monomers having one or more functional groups selected from: hydroxyl, carboxylic acid, anhydride, acyl halide, alkyl halide, acid anhydride, acrylate, methacrylate, aldehyde, amide, amine, guanidine, malimide, thiol, sulfonate, sulfonic acid, sulfonyl ester, carbodiimide, ester, cyano, epoxide, proline, disulfide, imidazole, imide, imine, isocyanate, isothiocyanate, nitro, azide, and combinations thereof. 16. The method of claim 4 wherein the step-growth polymerization process for the porous polymer monolith material comprises the polymerization of one or more monomers having one or more functional groups selected from: hydroxyl, carboxylic acid, anhydride, acyl halide, alkyl halide, acid anhydride, acrylate, methacrylate, aldehyde, amide, amine, guanidine, malimide, thiol, sulfonate, sulfonic acid, sulfonyl ester, carbodiimide, ester, cyano, epoxide, proline, disulfide, imidazole, imide, imine, isocyanate, isothiocyanate, nitro, azide, and combinations thereof. 17. The method of claim 13, wherein the acrylic acid monomer is a methacrylate monomer. 18. The method of claim 14, wherein the acrylic acid monomer is a methacrylate monomer. 19. The method of claim 15, wherein the acrylic acid monomer is a methacrylate monomer. 20. The method of claim 16, wherein the acrylic acid monomer is a methacrylate monomer. 21. The method of claim 17 wherein the methacrylate monomer is selected from hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EDMA). 22. The method of claim 18 wherein the methacrylate monomer is selected from hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EDMA). 23. The method of claim 19 wherein the methacrylate monomer is selected from hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EDMA). 24. The method of claim 20 wherein the methacrylate monomer is selected from hydroxyethyl methacrylate (HEMA) and ethylene glycol dimethacrylate (EDMA).
法律状态
GRANTED
专利类型码
B2A1
国别省市代码
若您需要申请原文,请登录。

最新评论

暂无评论。

登录后可以发表评论

意见反馈
返回顶部